Kevin Patrick Moran

Entity
Individual
Business address
C/O Vanda Pharmaceuticals Inc., 2200 Pennsylvania Avenue, Suite 300 E, 20037 Washington, DC
Insider ownership signature
/s/ Kevin Patrick Moran
All SEC filings
View on sec.gov
Get insider transactions for this reporting owner
Kevin Patrick Moran has filed 22 SEC EDGAR filings since 3/24/2020

Latest Filings

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open Document Open Filing 4 Mar 4, 2025 Mar 1, 2025 001-34186
4 Open Document Open Filing 4 Feb 24, 2025 Feb 21, 2025 001-34186
4 Open Document Open Filing 4 Feb 20, 2025 Feb 18, 2025 001-34186
4 Open Document Open Filing 4 Jul 29, 2024 Jul 29, 2024 001-34186
144 Open Document Open Filing Jul 29, 2024
4 Open Document Open Filing 4 Mar 6, 2024 Mar 4, 2024 001-34186
144 Open Document Open Filing Mar 4, 2024
4 Open Document Open Filing 4 Feb 21, 2024 Feb 16, 2024 001-34186
4 Open Document Open Filing FORM 4 SUBMISSION Aug 1, 2023 Jul 28, 2023 001-34186
144 Open Document Open Filing Jul 28, 2023
4 Open Document Open Filing FORM 4 SUBMISSION Jun 20, 2023 Jun 15, 2023 001-34186
144 Open Document Open Filing Jun 15, 2023
4 Open Document Open Filing FORM 4 SUBMISSION Mar 6, 2023 Mar 2, 2023 001-34186
4 Open Document Open Filing FORM 4 SUBMISSION Feb 21, 2023 Feb 16, 2023 001-34186
4 Open Document Open Filing FORM 4 SUBMISSION Dec 7, 2022 Dec 6, 2022 001-34186
4 Open Document Open Filing FORM 4 SUBMISSION Aug 1, 2022 Jul 28, 2022 001-34186
4 Open Document Open Filing FORM 4 SUBMISSION Mar 2, 2022 Feb 28, 2022 001-34186
4 Open Document Open Filing FORM 4 SUBMISSION Jul 30, 2021 Jul 28, 2021 001-34186
4 Open Document Open Filing FORM 4 SUBMISSION Mar 3, 2021 Mar 1, 2021 001-34186
4 Open Document Open Filing FORM 4 SUBMISSION Feb 26, 2021 Feb 24, 2021 001-34186
4 Open Document Open Filing FORM 4 SUBMISSION Jul 29, 2020 Jul 27, 2020 001-34186
3 Open Document Open Filing FORM 3 SUBMISSION Mar 24, 2020 Mar 15, 2020 001-34186